Cargando…
Inpatient pediatric antimicrobial use for respiratory infections during the RSV surge
Background: In the United States, pneumonia causes >100,000 pediatric hospitalizations annually. On November 4, 2022, the CDC issued a Heath Advisory concerning an upcoming surge of respiratory illnesses including SARS-CoV-2, influenza, and respiratory syncytial virus (RSV). Differentiating betwe...
Autores principales: | Hunt, Aaron, Burgos, Rodrigo, Lora, Alfredo Mena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594125/ http://dx.doi.org/10.1017/ash.2023.213 |
Ejemplares similares
-
Assessing inpatient antibiotic use during COVID-19 surges with or without infectious diseases consultation
por: Tommasi, Nicole, et al.
Publicado: (2023) -
Teams in transition: Increasing role of advanced practice providers in inpatient antimicrobial use
por: Perez, Reinaldo, et al.
Publicado: (2023) -
Factors associated with antimicrobial drug prescription among inpatient dogs and cats at an academic veterinary hospital
por: Price, Emma, et al.
Publicado: (2022) -
Reductions in Postdischarge Clostridioides difficile Infection after an Inpatient Health System Fluoroquinolone Stewardship
por: Ashley Jones, K., et al.
Publicado: (2021) -
Antimicrobial stewardship during COVID-19: An analysis of culture negative patients receiving extended antimicrobial agents
por: Srialluri, Swetha, et al.
Publicado: (2023)